{"id":"https://openalex.org/W1971875889","doi":"https://doi.org/10.1016/j.amjhyper.2004.07.001","title":"Of the renin-angiotensin system and reactive oxygen speciesType 2 diabetes and angiotensin II inhibition","display_name":"Of the renin-angiotensin system and reactive oxygen speciesType 2 diabetes and angiotensin II inhibition","alternate_titles":[],"publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W1971875889","doi":"https://doi.org/10.1016/j.amjhyper.2004.07.001","mag":"1971875889","pmid":"https://pubmed.ncbi.nlm.nih.gov/15691626"},"language":"en","primary_location":{"id":"doi:10.1016/j.amjhyper.2004.07.001","doi":"https://doi.org/10.1016/j.amjhyper.2004.07.001","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.amjhyper.2004.07.001","pdf_url":null,"source":{"id":"https://openalex.org/S128891601","display_name":"American Journal of Hypertension","issn_l":"0895-7061","issn":["0895-7061","1941-7225"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hypertension","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1971875889"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080414941","display_name":"Lawrence A. Leiter","orcid":"https://orcid.org/0000-0002-1040-6229","observed_orcids":["https://orcid.org/0000-0002-1040-6229"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"L LEITER","raw_affiliation_strings":["University of Toronto, Ontario, Canada. leiter@smh.toronto.on.ca","University of Toronto , Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Toronto, Ontario, Canada. leiter@smh.toronto.on.ca","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"University of Toronto , Ontario","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111633484","display_name":"Richard Z. Lewanczuk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R LEWANCZUK","raw_affiliation_strings":["University of Alberta, Edmonton, Canada","University of Alberta, Edmonton, Canad\u00e1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, Canada","institution_ids":["https://openalex.org/I154425047"]},{"raw_affiliation_string":"University of Alberta, Edmonton, Canad\u00e1","institution_ids":["https://openalex.org/I154425047"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5080414941"],"corresponding_institution_ids":["https://openalex.org/I185261750"],"apc_list":{"value":4814,"currency":"USD","value_usd":4814},"apc_paid":null,"fwci":7.5689,"has_fulltext":false,"cited_by_count":126,"citation_normalized_percentile":{"value":0.97592393,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"18","issue":"1","first_page":"121","last_page":"128"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.9319999814033508},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8090000152587891},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.9210000038146973},{"id":"https://openalex.org/keywords/angiotensin-ii-receptor-blockade","display_name":"angiotensin II receptor blockade","score":0.7369999885559082},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.8259999752044678},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.8519999980926514},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.8849999904632568},{"id":"https://openalex.org/keywords/free-fatty-acids","display_name":"free fatty acids","score":0.9879999756813049},{"id":"https://openalex.org/keywords/adipogenic-differentiation","display_name":"adipogenesis","score":0.9819999933242798},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.6230000257492065},{"id":"https://openalex.org/keywords/nuclear-factor-kappab","display_name":"nuclear factor-kappaB","score":0.7620000243186951},{"id":"https://openalex.org/keywords/beta-cell-dysfunction","display_name":"beta-cell dysfunction","score":0.8849999904632568},{"id":"https://openalex.org/keywords/diabetes-prevention","display_name":"diabetes prevention","score":0.6800000071525574},{"id":"https://openalex.org/keywords/renin-angiotensin-system-inhibitors","display_name":"renin-angiotensin system inhibitors","score":0.7160000205039978},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.44200000166893005},{"id":"https://openalex.org/keywords/atherogenesis","display_name":"atherogenesis","score":0.6919999718666077},{"id":"https://openalex.org/keywords/insulin-stimulated-glucose-uptake","display_name":"insulin-stimulated glucose uptake","score":0.7310000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8891434669494629},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.7317556738853455},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6095266342163086},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5551227331161499},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.550570547580719},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.42562341690063477},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.317147821187973}],"mesh":[{"descriptor_ui":"D000804","descriptor_name":"Angiotensin II","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D005230","descriptor_name":"Fatty Acids, Nonesterified","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018384","descriptor_name":"Oxidative Stress","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.amjhyper.2004.07.001","doi":"https://doi.org/10.1016/j.amjhyper.2004.07.001","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.amjhyper.2004.07.001","pdf_url":null,"source":{"id":"https://openalex.org/S128891601","display_name":"American Journal of Hypertension","issn_l":"0895-7061","issn":["0895-7061","1941-7225"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hypertension","raw_type":"journal-article"},{"id":"pmid:15691626","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15691626","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of hypertension","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":80,"referenced_works":["https://openalex.org/W1529592271","https://openalex.org/W1877352094","https://openalex.org/W1907915877","https://openalex.org/W1944240762","https://openalex.org/W1970582410","https://openalex.org/W1971720175","https://openalex.org/W1972990982","https://openalex.org/W1977949985","https://openalex.org/W1979030376","https://openalex.org/W1979804924","https://openalex.org/W1981237781","https://openalex.org/W1981851376","https://openalex.org/W1983046008","https://openalex.org/W1986446951","https://openalex.org/W1990773395","https://openalex.org/W1991952295","https://openalex.org/W1992777999","https://openalex.org/W1994527422","https://openalex.org/W1995940522","https://openalex.org/W1998221258","https://openalex.org/W2007877504","https://openalex.org/W2009165423","https://openalex.org/W2012898950","https://openalex.org/W2018135697","https://openalex.org/W2021976026","https://openalex.org/W2023931585","https://openalex.org/W2024144684","https://openalex.org/W2030338284","https://openalex.org/W2031408580","https://openalex.org/W2036464010","https://openalex.org/W2044773944","https://openalex.org/W2051181865","https://openalex.org/W2054536091","https://openalex.org/W2055124499","https://openalex.org/W2056976690","https://openalex.org/W2062386281","https://openalex.org/W2067895655","https://openalex.org/W2074712105","https://openalex.org/W2076066102","https://openalex.org/W2076122324","https://openalex.org/W2079793296","https://openalex.org/W2081275762","https://openalex.org/W2083990676","https://openalex.org/W2092433530","https://openalex.org/W2099538549","https://openalex.org/W2101700242","https://openalex.org/W2102979143","https://openalex.org/W2112726636","https://openalex.org/W2114722474","https://openalex.org/W2114816889","https://openalex.org/W2118286022","https://openalex.org/W2120282127","https://openalex.org/W2122966913","https://openalex.org/W2128647577","https://openalex.org/W2129380027","https://openalex.org/W2132105747","https://openalex.org/W2133217116","https://openalex.org/W2135038122","https://openalex.org/W2135435480","https://openalex.org/W2137737171","https://openalex.org/W2139126524","https://openalex.org/W2140106465","https://openalex.org/W2143478764","https://openalex.org/W2143766937","https://openalex.org/W2144810869","https://openalex.org/W2145531504","https://openalex.org/W2146507509","https://openalex.org/W2149119098","https://openalex.org/W2152280966","https://openalex.org/W2156121263","https://openalex.org/W2156783035","https://openalex.org/W2160848960","https://openalex.org/W2161257972","https://openalex.org/W2163142501","https://openalex.org/W2172032309","https://openalex.org/W2325499667","https://openalex.org/W2332951586","https://openalex.org/W2946929330","https://openalex.org/W3021250193","https://openalex.org/W4256592710"],"related_works":["https://openalex.org/W2385102116","https://openalex.org/W2050107488","https://openalex.org/W2151871061","https://openalex.org/W2353523461","https://openalex.org/W2104340865","https://openalex.org/W2160203698","https://openalex.org/W2313314614","https://openalex.org/W2318520162","https://openalex.org/W2069711524"],"abstract_inverted_index":{"Rates":[0],"of":[1,65,85,99,119,135,159,191,203,233,244,260,282,293,343,351,362,399],"type":[2,87,149,353,363],"2":[3,88,150,354,364],"diabetes":[4,89,245,365],"mellitus":[5],"are":[6,220,366],"increasing":[7],"worldwide":[8],"at":[9,146,349],"an":[10,162,319,329],"explosive":[11],"rate.":[12],"This":[13,91,172],"\"epidemic\"":[14],"is":[15,24,139,165,174,184,266,328,395],"largely":[16],"driven":[17],"by":[18,96,107,176,186],"a":[19,97,238,247],"concomitant":[20,37],"obesity":[21],"epidemic,":[22],"which":[23,102,208,296,394],"seen":[25],"not":[26],"only":[27],"in":[28,32,69,133,144,156,241,324,347,386],"affluent":[29],"countries,":[30],"but":[31],"industrializing":[33],"countries":[34],"as":[35,51,111,122,124,286],"well,":[36],"with":[38,372],"the":[39,70,77,83,117,140,192,201,231,242,258,280,310,314,340,345,360,368,380],"rapid":[40],"change":[41],"toward":[42],"Western":[43],"life-style":[44],"patterns":[45],"worldwide.":[46],"Recent":[47],"clinical":[48,334],"trials":[49,335,358],"such":[50,110,285,357],"Heart":[52],"Outcomes":[53,390],"Prevention":[54],"Evaluation":[55],"(HOPE),":[56],"Losartan":[57],"Intervention":[58],"for":[59,148,167,332],"Endpoint":[60],"reduction":[61,173],"(LIFE),":[62],"and":[63,67,116,126,179,215,230,246,255,263,270,275,290,300,306,374,379,384],"Study":[64],"Cognition":[66],"Prognosis":[68],"Elderly":[71],"(SCOPE)":[72],"have":[73,318],"indicated":[74],"that":[75,164,205,224,268],"blocking":[76,344],"renin-angiotensin":[78],"system":[79],"(RAS)":[80],"may":[81,93],"reduce":[82],"risk":[84,147,250,259,350],"developing":[86,352],"mellitus.":[90],"effect":[92,320],"be":[94,105],"explained":[95],"variety":[98],"diabetogenic":[100],"factors,":[101],"seem":[103],"to":[104,199,210,279,303,317,338],"moderated":[106],"angiotensin":[108,177,193],"II,":[109],"free":[112],"fatty":[113],"acids":[114],"(FFA)":[115],"phenomena":[118],"adipocyte":[120],"differentiation,":[121],"well":[123],"inflammation":[125],"oxidative":[127,276],"damage.":[128],"Insulin":[129],"resistance,":[130],"usually":[131],"present":[132],"cases":[134],"impaired":[136],"glucose":[137,170,182],"tolerance,":[138],"major":[141,239,248],"identifiable":[142],"defect":[143],"subjects":[145],"diabetes.":[151,355],"Elevated":[152],"FFA":[153,213],"levels":[154,214],"result":[155],"reduced":[157,211],"activation":[158,229,281],"phosphoinositol-3":[160],"kinase,":[161],"enzyme":[163],"essential":[166],"normal":[168],"insulin-stimulated":[169,181],"uptake.":[171],"potentiated":[175],"II":[178,194],"consequently":[180],"uptake":[183],"improved":[185],"RAS":[187,315,346],"inhibition.":[188],"Furthermore,":[189],"blockade":[190,226],"AT(1)-receptor":[195,225],"has":[196],"been":[197],"shown":[198],"stimulate":[200],"differentiation":[202],"adipocytes":[204],"store":[206],"FFAs,":[207],"leads":[209],"plasma":[212],"decreased":[216],"insulin":[217,261,298],"resistance.":[218],"There":[219,327],"also":[221,396],"data":[222],"suggesting":[223],"reduces":[227],"inflammatory":[228],"production":[232,274],"reactive":[234],"oxygen":[235],"species":[236],"(ROS),":[237],"factor":[240,288],"pathophysiology":[243],"cardiovascular":[249,400],"factor.":[251],"Both":[252],"proinflammatory":[253],"molecules":[254,284],"ROS":[256,273],"increase":[257,272],"resistance":[262,299],"atherogenesis.":[264],"It":[265],"thought":[267],"FFAs":[269],"hyperglycemia":[271],"stress,":[277],"leading":[278],"signaling":[283],"nuclear":[287],"kappa-B":[289],"other":[291],"mediators":[292],"stress-sensitive":[294],"pathways,":[295],"increases":[297],"will":[301],"lead":[302],"beta-cell":[304],"dysfunction":[305],"diabetic":[307],"complications":[308],"during":[309],"longer":[311],"term.":[312],"Inhibiting":[313],"seems":[316],"on":[321,359],"several":[322],"steps":[323],"this":[325],"cascade.":[326],"obvious":[330],"need":[331],"large-scale":[333],"specifically":[336],"designed":[337],"assess":[339],"protective":[341],"benefits":[342],"individuals":[348],"Two":[356],"prevention":[361,398],"ongoing,":[367],"Diabetes":[369],"Reduction":[370],"Assessment":[371],"Ramipril":[373],"Rosiglitazone":[375],"Medications":[376],"(DREAM)":[377],"study":[378],"more":[381],"ambitious":[382],"Nateglinide":[383],"Valsartan":[385],"Impaired":[387],"Glucose":[388],"Tolerance":[389],"Research":[391],"(NAVIGATOR)":[392],"trial,":[393],"assessing":[397],"events.":[401]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1971875889","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
